The hypophospatasia treatment market is projected to grow from USD 16.9 million in 2025 to USD 27.6 million by 2035, at a CAGR of 5.0%. Odontohypophosphatasia will dominate with a 54.0% market share, while medication will lead the treatment type segment with a 72.5% share.